Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/01/2855119/0/en/CervoMed-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Corporate-Updates.html
https://www.globenewswire.com/news-release/2024/03/28/2854468/0/en/CervoMed-to-Participate-in-Upcoming-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/03/28/2853996/0/en/CervoMed-Announces-Up-to-149-4-Million-Private-Placement-Financing-Joined-by-Leading-Healthcare-Investors.html
https://www.globenewswire.com//news-release/2024/03/05/2840366/0/en/CervoMed-Announces-Presentation-of-Biomarker-Data-from-the-AscenD-LB-Phase-2a-Trial-and-Preclinical-Data-Supporting-Potential-of-Neflamapimod-in-Tau-Mediated-Disease-at-AD-PD-2024.html
https://www.globenewswire.com//news-release/2024/02/21/2832709/0/en/CervoMed-to-Participate-in-the-BIO-CEO-and-Investor-Conference.html
https://www.globenewswire.com//news-release/2024/02/12/2827467/0/en/CervoMed-Publishes-Positive-Results-from-AscenD-LB-Phase-2a-Trial-in-Peer-Reviewed-Journal-that-Supports-the-Therapeutic-Potential-of-Neflamapimod-in-Dementia-with-Lewy-Bodies.html
https://www.globenewswire.com//news-release/2024/02/07/2825197/0/en/CervoMed-Announces-Appointment-of-Industry-Leader-Joshua-Boger-Ph-D-as-Chair-of-the-Board.html
https://www.globenewswire.com//news-release/2024/02/05/2823489/0/en/CervoMed-to-Participate-in-the-Emerging-Growth-Conference-67.html
https://www.globenewswire.com//news-release/2024/01/05/2804604/0/en/CervoMed-to-Participate-in-the-Emerging-Growth-Conference-66.html
https://www.prnewswire.com/news-releases/cervomed-to-present-at-the-2023-roth-healthcare-opportunities-conference-301945841.html